Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate disease progression in patients coinfected with HIV. However, recent evidence suggests that HTLV-II has no effect on HIV disease progression. In addition, it has recently been reported that HIV viral load was not increased in subjects coinfected with HTLV-I, suggesting that the biologic basis for the hypothesis does not exist. Several recent studies in Brazil, however, suggest that coinfection with HTLV-I and HIV has substantial medical consequences. For example, coinfection was associated with a higher CD4 lymphocytes count following adjustment for HIV viral load or HIV clinical stage. In addition, coinfected subjects have a high prevalence of clinical significant myelopathy. The effect of other putative viruses as cofactors in HIV disease progression is also discussed.

[1]  L. Mole,et al.  The impact of active herpes simplex virus infection on human immunodeficiency virus load. , 1997, The Journal of infectious diseases.

[2]  T. Quinn,et al.  Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. , 1997, The Journal of infectious diseases.

[3]  T. Quinn,et al.  Myelopathy Among Brazilians Coinfected with Human T-cell Lymphotropic Virus Type I and HIV , 1997, Neurology.

[4]  P. Kissinger,et al.  Retroviral coinfections at a New Orleans HIV outpatient clinic. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[5]  D. Vlahov,et al.  An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. , 1996, The Journal of infectious diseases.

[6]  L. Saravolatz,et al.  Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. , 1996, The Journal of infectious diseases.

[7]  C H Fox,et al.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.

[8]  H. Lederman,et al.  Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  W. Heneine,et al.  Investigation of proviral load in individuals infected with human T-lymphotropic virus type II. , 1995, AIDS research and human retroviruses.

[10]  J. Mellors,et al.  Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.

[11]  M. Tagliati,et al.  Neurologic Manifestations of HIV Infection , 1994, Annals of Internal Medicine.

[12]  M. Morfini,et al.  Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite. , 1994, Thrombosis and haemostasis.

[13]  B. Gazzard,et al.  Effects of high‐dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double‐blind, placebo‐controlled study , 1994 .

[14]  R. Detels,et al.  Persistent cytomegalovirus infection of semen increases risk of AIDS. , 1994, The Journal of infectious diseases.

[15]  J. Goedert,et al.  Cytomegalovirus Infection and Risk of AIDS in Human Immunodeficiency Virus-Infected Hemophilia Patients , 1993 .

[16]  M. Moroni,et al.  The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS‐related complex: a double‐blind, randomized trial , 1993 .

[17]  B. Hjelle,et al.  Chronic neurodegenerative disease associated with HTLV-II infection , 1992, The Lancet.

[18]  T. M. Hartley,et al.  Seroprevalence of HTLV-I and HTLV-II among Intravenous Drug Users and Persons in Clinics for Sexually Transmitted Diseases , 1992 .

[19]  C. Key,et al.  Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. , 1991, The Journal of infectious diseases.

[20]  L. Resnick,et al.  The role of HTLV in HIV‐1 neurologic disease , 1991, Neurology.

[21]  W. Blattner,et al.  The epidemiology of the human T‐cell lymphotrophic virus type I and type II: etiologic role in human disease , 1991, Transfusion.

[22]  J. Phair,et al.  Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. , 1990, American journal of public health.

[23]  Ruben Sm,et al.  Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein. , 1990 .

[24]  G. Mufti,et al.  Co-infection with HTLV-I/II and HIV-1 , 1990, The Lancet.

[25]  N. Klimas,et al.  HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users , 1990, The Lancet.

[26]  P. Griffiths,et al.  CYTOMEGALOVIRUS INFECTION AND PROGRESSION TOWARDS AIDS IN HAEMOPHILIACS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1989, The Lancet.

[27]  T. Quinn,et al.  AIDS in the Americas: an emerging public health crises. , 1989, New England Journal of Medicine.

[28]  B. Franza,et al.  Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins , 1989, Journal of virology.

[29]  J. Goedert,et al.  Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.

[30]  W. Blattner,et al.  PROGRESSION TO AIDS IN HOMOSEXUAL MEN CO-INFECTED WITH HIV AND HTLV-I IN TRINIDAD , 1987, The Lancet.

[31]  M. Aboud,et al.  Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients. , 1987, Leukemia.

[32]  S. Izumo,et al.  Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells , 1987, Annals of neurology.

[33]  W. Wachsman,et al.  A second isolate of HTLV-II associated with atypical hairy-cell leukemia. , 1986, The New England journal of medicine.

[34]  M. Robert-Guroff,et al.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.

[35]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[36]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.